Glactone Pharma Development AB is a Swedish AB based in Göteborg, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2012, the company has 0 employees and reported revenue of SEK 80.0k in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget skall bedriva forskning, utveckling, utbildning, marknadsföring och försäljning inom det medicinska området samt idka därmed förnelig verksamhet.
In its most recent annual report (2024), Glactone Pharma Development AB reported revenue of SEK 80.0k, broadly in line with the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of SEK 3.0k, and the EBITDA margin stood at 35%.
At the end of 2024, equity financed 47.1% of the balance sheet, and current assets covered short-term debt 0.1 times.
Frequently asked questions
What is the Org number of Glactone Pharma Development AB?
Glactone Pharma Development AB is registered with Bolagsverket / SCB under Org 5569121121.
What is the revenue of Glactone Pharma Development AB?
Glactone Pharma Development AB reported revenue of SEK 80.0k in 2024.
Who is the chairman of Glactone Pharma Development AB?
Jan Birger Fredrik Törnell chairs the board of Glactone Pharma Development AB, in role since 2020.
Where is Glactone Pharma Development AB headquartered?
Glactone Pharma Development AB's registered address is Kungsportsavenyen 22.
